The PBM Transparency Act Will Not Lower Drug Prices

While members of Congress agree on the need to try to rein in the prices of prescription drugs, there is less consensus as to how this might be accomplished. Unfortunately, some of the ideas currently...

The FTC’s Fight Against Non-Monopolies Won’t Help Consumers

Popular Bloomberg News columnist Matt Levine likes to make a comical point in his popular Moneystuff column for Bloomberg that from the SEC’s perspective nearly everything a company does (or its execu...

Pharma’s Strategy To Exploit A Depression-Era Antitrust Law Would Raise Drug Costs For Consumers

The prescription drug market is bewildering to many, and its complexity can make rational discussions about the causes of high drug prices exceedingly difficult. It also means that government official...

Rite Aid Touts PBM, Other Assets Amid Buyout Rumblings

Rite Aid CEO Heyward Donigan is telling shareholders the company remains “focused on the continued … [+] transformation of Rite Aid into a leading full-service pharmacy company,” the companyR...